Merck, Moderna say melanoma vaccine meets goals in large trial ReutersPersonalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial CNBCModerna stock is soaring in premarket after encouraging trial of cancer vaccine MarketWatchModerna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial STATCancer treatment could face landmark moment with promising vaccine The Washington Post